How Does COVID-19 Affect People with HIV?

We are still learning about COVID-19 and how it affects people with HIV. Nearly half of people in the United States with diagnosed HIV are ages 50 and older. People with HIV also have higher rates of certain underlying health conditions. Older age and underlying medical conditions can make people more likely to get very sick if they get COVID-19. This is especially true for people with advanced HIV or people with HIV who are not on treatment.

People at increased risk for severe illness, and those who live with or visit them, should take precautions (including getting vaccinated and wearing a well-fitting mask) to protect themselves and others from COVID-19.

Feeling sick? Call your health care provider if you develop symptoms that could be consistent with COVID-19. Keep taking your HIV medicine as prescribed. This will help keep your immune system healthy. If you are not taking HIV medicine, talk to your health care provider about the benefits of getting on HIV treatment. Learn more about what to do if you get sick.

COVID-19 Treatment. If you have possible symptoms of COVID-19, have had a positive test, or have been exposed to the virus that causes COVID-19, talk to your health care provider to see if you’re eligible for COVID-19 treatment or preventive medicine. You can also visit a Test to Treat location and, if eligible, receive a prescription from a provider. Don’t delay: COVID-19 treatment must be started within the first few days to be effective. But be aware: some COVID-19 treatments can interact with antiretroviral therapy (ART) used to treat HIV. If you have HIV, let your health care provider know before starting COVID-19 treatment. However, there are no known interactions between ART and the medicine used to prevent COVID-19 (Evusheld). For people without HIV, there is also no evidence that currently available medicine used to prevent or treat COVID-19 will interact with pre-exposure prophylaxis (PrEP) to prevent HIV.

COVID-19 Vaccines and People with HIV

Get vaccinated. COVID-19 vaccines are recommended for everyone ages 6 months and older including people with HIV, regardless of their CD4 count or viral load. The number of vaccine doses you need depends on your age and the type of vaccine you receive.

Additional primary shot. After completing the COVID-19 vaccine primary series, some people who have advanced HIV (including an AIDS diagnosis) or who have HIV and are not taking HIV treatment should get an additional primary shot. This additional primary shot is intended to improve a person’s immune response to their two-dose COVID-19 vaccine primary series. People who are eligible for this additional primary shot should receive this dose before they get a booster shot. CDC does not recommend an additional primary shot of the COVID-19 vaccine for people with HIV who are virally suppressed or who do not have advanced HIV. Talk to your health care provider to determine if getting an additional primary shot is right for you.

Booster shots. Booster shots are an important part of protecting yourself from getting seriously ill or dying from COVID-19. CDC recommends that everyone, including people with HIV, get a booster shot when they are eligible. Use CDC’s COVID-19 booster tool to learn if you should get a booster, when to get a booster, and which booster you should get.

Vaccine safety. COVID-19 vaccines are safe for people with HIV. COVID-19 vaccines meet the Food and Drug Administration’s rigorous scientific standards for safety, effectiveness, and manufacturing quality and people with HIV were included in vaccine clinical trials.

There is no evidence that COVID-19 vaccines interfere with ART or with pre-exposure prophylaxis (PrEP) to prevent HIV. Learn more about vaccine safety.

If you have questions about getting COVID-19 vaccine and whether it is right for you, talk to your health care provider.

Visit vaccines.gov or text your ZIP code to GETVAX (438829) in English or VACUNA (822862) in Spanish to find COVID-19 vaccines near you.

COVID-19 and HIV: Federal Resources

Below are resources about COVID-19 from agencies across the federal government for people with HIV and the health care providers and organizations who work with them. Information is regularly being updated as we learn more in this evolving situation.

Centers for Disease Control and Prevention (CDC)

• CDC.gov/coronavirus —This site provides the latest public health and safety information on COVID-19 from CDC for consumers and the medical and health provider community.
• COVID-19 and People with Certain Medical Conditions—This page provides information for people with certain medical conditions (including HIV) associated with a higher risk for severe COVID-19.
• COVID-19 Pre-exposure Prophylaxis (Evusheld)—This page offers information about Evusheld, a medicine to help prevent COVID-19 infection in people who are moderately or severely immunocompromised, including people with advanced or untreated HIV.
• COVID-19 Vaccines for Moderately to Severely Immunocompromised People—This page offers information for people who are moderately to severely immunocompromised, including those with advanced or untreated HIV.
• HIV and COVID-19 | CDC—This page features FAQs about HIV and COVID-19.
• HIV Self-Testing Guidance—This CDC guidance addresses the use of HIV self-testing programs during the COVID-19 pandemic.
• Older Adults: COVID-19 Risks and Vaccine Information—This page provides information COVID-19 risks and vaccines and for older adults. More than half of people in the U.S. with diagnosed HIV are over age 50.
• People Who Are Immunocompromised—This page provides information for people who are immunocompromised, including people with advanced or untreated HIV, can protect themselves from COVID—and what to do if they get sick.
• People Who Use Drugs or Have Substance Use Disorder: COVID-19 Risk and Severity—This page provides COVID-19 information for people who use drugs or have substance use disorder and their loved ones.
• PrEP During COVID-19—This CDC guidance addresses the provision of pre-exposure prophylaxis (PrEP) for HIV during the COVID-19 epidemic.

Health Resources and Services Administration (HRSA)

• COVID-19 Information for Health Centers and Partners—This HRSA Health Center Program page provides the latest information on COVID-19 for health centers and Health Center Program partners. HRSA-funded health centers are a vital part of the nation’s response to HIV.
• HRSA HAB COVID-19 Information—This HRSA HIV/AIDS Bureau (HRSA HAB) page provides links to resources for Ryan White HIV/AIDS Program (RWHAP) recipients, subrecipients, and stakeholders who are responding to COVID-19. It includes links to RWHAP COVID-19 FAQs, technical assistance information for CARES Act RWHAP award recipients, and audio and transcripts from HRSA HAB’s program policy and technical assistance webinars.
• HRSA.gov/coronavirus—This page provides COVID-19 information specific to all HRSA programs and grantees.

Indian Health Service (IHS)

• IHS.gov/coronavirus—This web page provides Information specific to the federal response in Indian Country.

National Institutes of Health (NIH)

• COVID-19 Prevention Trials Network (COVPN)Exit Disclaimer—The CoVPN seeks to enroll thousands of volunteers in large-scale clinical trials of COVID-19 vaccines and monoclonal antibodiesExit Disclaimer. It was formed by merging NIAID-funded clinical trial networks, including three that target HIV and AIDS. Interested individuals can sign up to participate in these trials.
• Guidance for COVID-19 and Persons with HIV—This guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19.
• NIH Mental Health Resources—NIH has compiled this library of mental health resources related to COVID-19 and mental illnesses and disorders. Good mental health is essential to successfully treating HIV.
• NIDA: Resources to Help Your Patients with Substance Use Disorders (SUD) During the COVID-19 Pandemic—Given the comorbidity of HIV and SUD, this National Institute on Drug Abuse (NIDA) page may be of use to those who work with people with HIV.
• NIDA: COVID-19 and Substance Use—This NIDA page of COVID-19 resources includes FAQs on COVID-19 and addiction/substance use disorder.

Substance Abuse and Mental Health Services Administration (SAMHSA)

• SAMHSA.gov/coronavirus—This site provides guidance and resources on the prevention and treatment of those with mental health and SUD as it relates to COVID-19, including links to fact sheets on managing stress during COVID-19.

U.S. Department of Health and Human Services (HHS) Administration for Community Living

• Strategies to Improve Equitable Vaccine Access for Older Adults and People With Disabilities—This is a compilation of strategies and best practices for helping older adults and people with disabilities access COVID-19 vaccines. More than half of people in the U.S. with diagnosed HIV are over age 50.

U.S. Department of Health and Human Services (HHS) Office for Civil Rights

• HHS OCR Bulletin on Civil Rights Laws and HIPAA Flexibilities that Apply During the COVID-19 Emergency—This Bulletin is focused on ensuring that covered entities do not unlawfully discriminate against people with disabilities when making decisions about their treatment during the COVID-19 public health emergency. It includes addressing the needs of people with HIV in emergency planning.
• HHS OCR Guidance on Federal Legal Standards Prohibiting Disability Discrimination in COVID-19 Vaccination Programs—People with or at risk for HIV who have disabilities and those who work with them may find this information useful. (Related fact sheet.)

U.S. Department of Housing and Urban Development (HUD)

• HUD HOPWA COVID-19 Guidance and Resources—This page offers COVID-19 guidance, webinars, and other COVID-19 resources for the grantees of HUD’s Housing Opportunities for People with AIDS (HOPWA) Program.

U.S. Department of State

• PEPFAR’s HIV Response in the Context of COVID-19—The United States President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest commitment by any nation to address a single disease in history. This resource outlines PEPFAR’s ongoing HIV response in the context of COVID-19.